Market Overview

Janney Capital Initiates Coverage on Vertex Pharmaceuticals Incorporated at Buy, Announces $54.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for VRTX

DateFirmActionFromTo
Jul 2015JMP SecuritiesMaintainsMarket Outperform
Jul 2015Bank of AmericaMaintainsNeutral
Jul 2015Leerink SwannMaintainsOutperform

View More Analyst Ratings for VRTX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (VRTX)

Get Benzinga's Newsletters